NEW YORK, Feb. 18 (GenomeWeb News) - Abbott Laboratories will continue to use Compugen's Genecarta technology for analyzing novel drug targets, Compugen said today.

 

Under the extended agreement, which started in early 2003, Abbott will receive several updates of Compugen's Genecarta database.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.